Genome-Wide Identification of Bone Metastasis-Related MicroRNAs in Lung Adenocarcinoma by High-Throughput Sequencing

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Xie, Lin ^a   Yang, Zuozhang ^a   Li, Guoqi ^a   Shen, Lida ^a   Xiang, Xudong ^a   Liu, Xuefeng ^a   Xu, Da ^a   Xu, Lei ^a   Chen, Yanjin ^a   Tian, Zhao ^a   Chen, Xin ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CYTOSKELETON PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; WNT PROTEIN;

ADULT; ARTICLE; BONE METASTASIS; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; LUNG ADENOCARCINOMA; MALE; PRIMARY TUMOR; RNA SEQUENCE; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION;

ADENOCARCINOMA; BONE NEOPLASMS; FEMALE; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84875988605     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061212     Document Type: Article

References (35)

1. Alberg AJ, Ford JG, Samet JM, (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 29S-55S.
2. Wilson MA, Calhoun FW, (1981) The distribution of skeletal metastases in breast and pulmonary cancer: concise communication. J Nucl Med 22: 594-597.
3. Tofe AJ, Francis MD, Harvey WJ, (1975) Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans. J Nucl Med 16: 986-989.
4. Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, et al. (2012) Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study. J Thorac Oncol 7: 1823-1829.
5. Vashisht S, Bagler G, (2012) An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene ontology analysis. PLoS One 7: e49401.
6. Theriault RL, (2012) Biology of bone metastases. Cancer Control 19: 92-101.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
9. Zeng Y, Yi R, Cullen BR, (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 100: 9779-9784.
10. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
11. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
12. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
13. Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ, (2010) Development of the human cancer microRNA network. Silence 1: 6.
14. Malleter M, Jacquot C, Rousseau B, Tomasoni C, Juge M, et al. (2012) miRNAs, a potential target in the treatment of Non-Small-Cell Lung Carcinomas. Gene 506: 355-359.
15. Kosaka N, Iguchi H, Ochiya T, (2010) Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092.
16. Cho WC, (2011) Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis. Front Genet 2: 7.
17. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
18. Li R, Yu C, Li Y, Lam TW, Yiu SM, et al. (2009) SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25: 1966-1967.
19. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res.
20. Gardner PP, Daub J, Tate JG, Nawrocki EP, Kolbe DL, et al. (2009) Rfam: updates to the RNA families database. Nucleic Acids Res 37: D136-140.
21. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284.
22. The Gene Ontology: enhancements for 2011. Nucleic Acids Res 40: D559-564.
23. Zhang B, Kirov S, Snoddy J, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.
24. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480-484.
25. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827.
26. Ma L, Huang Y, Zhu W, Zhou S, Zhou J, et al. (2011) An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS One 6: e26502.
27. Wang G, Mao W, Zheng S, (2008) MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582: 3663-3668.
28. Ji S, Ye G, Zhang J, Wang L, Wang T, et al. (2012) miR-574-5p negatively regulates Qki6/7 to impact beta-catenin/Wnt signalling and the development of colorectal cancer. Gut.
29. Liu B, Wu X, Wang C, Liu Y, Zhou Q, et al. (2012) MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 1822: 1692-1704.
30. Kim NH, Kim HS, Li XY, Lee I, Choi HS, et al. (2011) A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 195: 417-433.
31. Wei J, Shi Y, Zheng L, Zhou B, Inose H, et al. (2012) miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol 197: 509-521.
32. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424.
33. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, et al. (2012) MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by down-regulating the Wnt/beta-catenin signaling pathway. Carcinogenesis.
34. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, et al. (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25: 13-20.
35. Sebastian C, Zwaans BM, Silberman DM, Gymrek M, Goren A, et al. (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151: 1185-1199.